` Comparison: STOK vs PNEXF - Alpha Spread

STOK
vs
PNEXF

Over the past 12 months, STOK has significantly outperformed PNEXF, delivering a return of +380% compared to the PNEXF's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
STOK
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

STOK Intrinsic Value
HIDDEN
Show
PNEXF Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Stoke Therapeutics Inc
NASDAQ:STOK
35.55 USD
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
STOK, PNEXF

STOK
PNEXF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Stoke Therapeutics Inc
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
STOK, PNEXF

STOK
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Stoke Therapeutics Inc
NASDAQ:STOK
Pharnext SCA
OTC:PNEXF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

STOK
0%
PNEXF
0%

Operating Margin

STOK
13.1%
PNEXF
-17 526.7%

Net Margin

STOK
20%
PNEXF
-21 040%

FCF Margin

STOK
25.6%
PNEXF
-15 953.3%

ROE

STOK
15.2%
PNEXF
114.6%

ROA

STOK
12.6%
PNEXF
-391.1%

ROIC

STOK
34.1%
PNEXF
3 092.9%

ROCE

STOK
9.6%
PNEXF
275.4%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
STOK, PNEXF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
STOK, PNEXF

Performance Gap Between STOK and PNEXF
HIDDEN
Show

Performance By Year
STOK, PNEXF

Loading
STOK
PNEXF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare STOK to other stocks
ABBV
Abbvie Inc
Cheaper
vs STOK
ATXS
Astria Therapeutics Inc
More expensive
vs STOK
AMGN
Amgen Inc
Cheaper
vs STOK
GILD
Gilead Sciences Inc
Cheaper
vs STOK
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett